15 Feb 2020
Antithrombotic therapy for AF in bioprosthetic valve
Sponsored by Daiichi Sankyo
Chairperson:
K. Hayashida
Summary
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Learning Objectives
- To understand anticoagulant therapy for bioprosthtic valves with AF
- To learn up-to-date of leaflet thrombosis
- To learn stroke prevetion after TAVI (antithrombotic therapy and left atrial appendage Closure)
